Business & Capabilities
Research & Development
It’s a known fact that “Experience brings Innovations”, at SMY Research & Development (R&D) center we have a team of extremely qualified scientists with more than 7 decades of cumulative team experience. Their diligent efforts help us to undertake various set of innovative activities for developing new products, and improving the existing ones. Not just that our R&D center objective is to develop new knowledge with constant learning from existing innovations.Newer molecules, better formulations &Novel drug delivery systems are key to make healthcare affordable with highest quality standards.
Our state-of-the-art R&D center is located in Yangon, Myanmar.
Manufacturing
Our state-of-the art, cGMP-compliant multi-product oral dosage formulation manufacturing facility is in 3000 sq. meters area in Dagon Seikkan Industrial Zone-1. Initial plan is to comply with WHO, PICS, EU-GMP, & TGA-Australia. Future plan is to get accreditation from US-FDA & UK-MHRA.
The facilities will be equipped with production of multi-product oral dosage formulation with the annual manufacturing capacity of 0.5 Billion pills.
Quality
At SMY Pharma we strongly believe in Quality fist policy. Highest Quality products can only delivery optimum efficacy. This leads to Trust & Confidence in developing better customer’s satisfaction. We are committed to deliver highest quality medicine by Ethical practices &Excellence in innovations.
We also believe that the key to success in a pharmaceutical manufacturing company is to improve process consistency with effective quality management system.We committed to deliver the best quality medicine through integrity, team work& transparency.
Our Business
We at SMY Pharma strongly understands that every customer is unique. Thus unique customers have exceptional needs & demands. We want to cater to each & every partner with 100% customer satisfaction. We believe in a sustainable network of alliances across the globe. We aim to grow by offering various business models like territory expansions, partnerships, globalization & further penetration through joint ventures and subsidiaries.
